$DCI

Donaldson shares gain 6% after fourth-quarter earnings and revenue beat forecasts

Donaldson Company (DCI) shares rose 6.07% premarket after Q4 earnings of $1.15 per share and revenue of $1.1 billion beat estimates. Sales grew 8% YoY, aided by the Facet acquisition. Despite lower-than-expected fiscal 2027 earnings guidance, margins improved and sales grew across all segments.

Original reporting
Published Aug 28, 2026, 12:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 1:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Donaldson shares gain 6% after fourth-quarter earnings and revenue beat forecasts — source image
Decision brief

The 30-second read

$DCIBullishHigh
01

Why it matters

The earnings beat drove a 6% pre‑market rally, while the softer guidance may limit further upside.

02

Market read

Earnings surprise creates short‑term trading opportunity; guidance may influence medium‑term positioning.

03

What to watch

Potential dilution from Facet acquisition and margin pressure could affect future profitability.

Relevance 8/10Novelty 8/10Timing: premarket today

Background

Donaldson Company reported Q4 2026 results, beating consensus on both EPS and revenue, and announced FY 2027 guidance.

Company-level read

Ticker impact

$DCIBullishHigh confidence
Context

Q4 earnings beat and revenue beat; guidance issued, causing 6% pre‑market price rise.

Expected impact

Expect modest further rise in pre‑market trading, but limited upside after guidance.

Evidence & confidence

Earnings beat and record sales drive immediate buying, while softer FY guidance tempers longer‑term rally.

Market effects

Industrial filtration sector may see broader strength as demand for filtration solutions rises.

U.S. industrial stocks could see modest lift from Donaldson's beat.

Limited; primarily impacts U.S. industrial and manufacturing investors.

Counterpoint

Guidance below expectations suggests earnings momentum may stall; consider short positions if price spikes.

Key entities

  • Donaldson Company

    Filtration products manufacturer (ticker DCI).

Related articles

$DCIMedAI 8/10

Donaldson’s (DCI) Billion-Dollar Quarter Hides A Costlier Bet Ahead

Donaldson Company (DCI) reported a record quarter with $1 billion in sales, an 8% increase, and adjusted EPS of $1.15, up 12%. Operating margin reached 17.5%, the highest ever. The company guided for another record year but noted increased interest costs and dilution from its largest acquisition. Aerospace and Industrial Filtration segments saw declines, and input costs from the Middle East conflict impacted margins.

$DCIHighAI 8/10

Donaldson (DCI) Q4 2026 Earnings Call Transcript

Donaldson (DCI) reported Q4 2026 revenue of $1 billion, up 8% YoY, and full-year sales of $3.9 billion, a 5% increase. Adjusted EPS rose 12% to $1.15. Fiscal 2027 guidance includes EPS of $4.22-$4.38 and revenue growth of 5.5%-9.5%. The company completed the Facet acquisition, expecting it to be accretive despite dilution. Management highlighted growth in Mobile Solutions and Life Sciences, but noted challenges in Aerospace and Defense due to supply chain constraints.

$DCIMedAI 8/10

Donaldson Co Inc (DCI) (Q4 2026) Earnings Call Highlights: Record Sales and EPS Fuel

Donaldson Co Inc (DCI) reported record fiscal 2026 results with sales of $3.9B, EPS of $3.98, and 16% operating margin. Q4 sales exceeded $1B, with adjusted EPS up 12% YoY. Strong aftermarket growth in Mobile Solutions and Facet acquisition performing as expected. Fiscal 2027 guidance projects $4.1B+ sales, 16.9% margin, and $4.30 EPS. Challenges include Mexico facility inefficiencies and supply chain constraints in Aerospace and Defense.

$DCIMedAI 8/10

Donaldson Company, Inc. Q4 2026 Earnings Call Summary

Donaldson Company reported record 2026 sales of $3.9B, driven by acquisitions and segment growth. It forecasts 2027 sales of $4.1B and operating margins of 16.6-17.2%. The Facet acquisition is expected to be $0.12 dilutive to EPS. Management expects operational recovery in H2 2027.